About
Upstream Bio, Inc. (NASDAQ:UPB) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 17 2026
Upstream Bio to Present New Data from Phase 2 VIBRANT Trial of Verekitug at the ATS 2026 International Conference
Mar 26 2026
Upstream Bio Highlights Phase 3 Development Strategy for Verekitug and Reports Fourth Quarter and Full Year 2025 Financial Results
Mar 1 2026
Upstream Bio Presents Additional Analyses from the Phase 2 VIBRANT Trial of Verekitug in Chronic Rhinosinusitis with Nasal Polyps at 2026 AAAAI Annual Meeting
Feb 26 2026
Upstream Bio to Present Additional Analyses from Phase 2 VIBRANT Trial in Chronic Rhinosinusitis with Nasal Polyps in Late-Breaking Session at AAAAI Annual Meeting 2026
Feb 25 2026
Upstream Bio to Participate in Upcoming March Investor Conferences
Financials
Revenue
$2.85 M
Market Cap
$567.06 M
EPS
-2.66
Google Übersetzer